Other secondary osteonecrosis, unspecified tibia
ICD-10 M87.363 is a billable code used to indicate a diagnosis of other secondary osteonecrosis, unspecified tibia.
Osteonecrosis, also known as avascular necrosis, is a condition characterized by the death of bone tissue due to a lack of blood supply. In the case of M87.363, the osteonecrosis is secondary, meaning it is a result of another underlying condition or factor, such as trauma, corticosteroid use, or certain medical conditions like sickle cell disease or systemic lupus erythematosus. The unspecified tibia indicates that the specific site within the tibia is not detailed, which can complicate treatment and management. Patients may present with pain, swelling, and limited range of motion in the affected limb. Diagnosis typically involves imaging studies such as X-rays or MRI to assess the extent of bone damage. Treatment options may include conservative management with pain relief, physical therapy, or surgical interventions such as core decompression or joint replacement, depending on the severity of the condition. Understanding the underlying cause of the osteonecrosis is crucial for effective management and prevention of further complications.
Detailed clinical notes on the patient's history, imaging results, and treatment plan.
Patients presenting with joint pain, history of corticosteroid use, or previous trauma.
Ensure that all contributing factors to osteonecrosis are documented to support the diagnosis.
Comprehensive assessment of systemic conditions that may contribute to osteonecrosis.
Patients with autoimmune diseases presenting with joint pain and risk factors for osteonecrosis.
Document any relevant laboratory findings or treatment history that may indicate secondary causes.
Used for pain management in patients with osteonecrosis.
Document the indication for the procedure and any imaging findings.
Orthopedic specialists should ensure that the procedure is linked to the diagnosis.
Common causes include trauma, corticosteroid use, excessive alcohol consumption, and certain medical conditions such as lupus or sickle cell disease.
Diagnosis typically involves imaging studies such as X-rays or MRI to assess the extent of bone damage and to rule out other conditions.
